NCEL CIK: 1783036

NewcelX Ltd.

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
2.31
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−15.5
FY23:
−11.8
FY24:
−2.07
FY25:
−2.56
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
−2.47
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
−3.28
FY24:
−7.20
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−16.5
FY23:
−3.33
FY24:
−7.20
FY25:
−8.30

All amounts in millions USD Data sources:SEC EDGARTwelve Data